Hosted on MSN3mon
SNUBH signs tripartite MOU for international PSP research centreGemVax & KAEL will play a role in funding the establishment of the centre and drive the research, development, and commercialisation of therapeutics for PSP. "SNUBH signs tripartite MOU for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback